Skip to main content
. 2022 Nov 9;26(6):1196–1209. doi: 10.1017/S1368980022002385

Table 1.

Characteristics of included studies on the association between yogurt consumption and mortality in adults aged > 18 years

Author Cohort name Country Age Sample size Follow-up Cases Outcome Exposure assessment Comparison RR 95 %CI Adjustment
Soedamah-Muthu et al. 2013 Whitehall II UK 35–55 M/F: 4522 11·7 237 All-cause mortality FFQ > 69 v. < 10 g/d HR: 0·74 0·53, 1·05 Age, ethnicity and employment grade, smoking, alcohol intake, BMI, physical activity and family history of CHD/hypertension, fruit and vegetables, bread, meat, fish, coffee, tea and total energy intake
Bonthuis et al. 2010 NSCS Australia 25–78 M/F: 1529 14·4 177 All-cause mortality FFQ > 30 v. < 2 g/d HR: 1·20 0·79, 1·83 Age, sex, total energy intake, BMI, alcohol intake, school leaving age, physical activity level, pack years of smoking, dietary supplement use, b-carotene treatment during trial and presence of any medical condition.
61 CVD mortality HR: 0·71 0·31, 1·65
Schmid et al. 2020 HPFS USA 40–75 M: 40 278 26 12 397 All-cause mortality FFQ > 4 serv/week v. never HR: 1·05 0·95, 1·16 Age, 2-year follow-up cycle, height, current BMI, BMI at the age of 18 years (women) or 21 years (men), ethnicity, physical activity, smoking status, pack-years of smoking, history of hypertension, history of hypercholesterolemia, history of diabetes, family history of cancer, family history of diabetes, family history of myocardial infarction, current multivitamin use, regular aspirin use, menopausal status and hormone use in women, total caloric intake, alcohol consumption, glycemic load, and intakes of unprocessed red meat, processed meat, nuts, total fibre, fruits, vegetables, and total Ca.
3733 CVD mortality HR: 0·95 0·79, 1·13
4000 Cancer mortality HR: 1·10 0·93, 1·30
NHS 30–55 F: 82 348 32 20 831 All-cause mortality > 4 serv/week v. never HR: 0·91 0·85, 0·98
4207 CVD mortality HR: 0·92 0·79, 1·08
7985 Cancer mortality HR: 0·87 0·78, 0·98
Farvid et al.2017 GCS Iran 36–85 F/M: 42 403 11 3291 All-cause mortality FFQ ≥ 0·75 v.≤ 0·2 serv/d HR: 0·89 0·79, 1·00 Sex, age, ethnicity, education, marital status, residency, smoking, opium use, alcohol use, BMI, systolic blood pressure, occupational physical activity, family history of cancer, wealth score, medication use and energy intake.
1467 CVD mortality HR:0·84 0·70, 1·00
859 Cancer mortality HR:0·86 0·69, 1·08
Dehghan et al. 2018 PURE 21 countries 35–70 F/M: 123 830 9·1 6796 All-cause mortality FFQ > 1 serv v. zero HR: 0·82 0·68, 0·98 Age, sex, education, urban or rural location, smoking status, physical activity, alcohol intake, history of diabetes, family history of CVD, family history of cancer, and quintiles of fruit, vegetable, red meat, starchy foods intake, and energy
Praagman et al. 2015 EPIC-NL The Netherlands 20–70 F/M: 34 409 15 2436 All-cause mortality FFQ > 104 v. < 15 g/d HR: 0·95 0·85, 1·07 Age, sex and total energy intake, smoking habit, BMI, physical activity, education level, hypertension at baseline, intakes of alcohol and energy-adjusted intakes of fruit and vegetables
726 CVD mortality HR:1·08 0·87, 1·34
1216 Cancer mortality HR:1·02 0·86, 1·21
Pala et al.2019 EPIC-Italy Italy 50·1 F/M: 45 009 14·9 2468 All-cause mortality FFQ > 120 v. 0 g/d HR:0·95 0·82, 1·09 Age, sex, centre, energy, weight, height, and waist-to-hip ratio; alcohol consumption; smoking status; physical activity; relative index of inequality; Italian Mediterranean Index; and intake of sugar.
459 CVD mortality HR:0·85 0·59, 1·23
1464 Cancer mortality HR:1·00 0·83, 1·20
Praagman et al.2014 RS The Netherlands > 55 F/M: 4235 17·3 576 Fatal CHD FFQ > 100 v. < 50 g/d HR: 0·98 0·76, 1·26 Age, gender, and total energy intake, BMI, smoking, education level, intakes of alcohol, vegetables, fruit, meat, bread, fish coffee, and tea
564 Fatal stroke HR: 1·01 0·71, 1·44
Park et al. 2007 NIH-AARP USA 50–71 M:293 888 6 178 Prostate cancer mortality FFQ ≥ 0·5 v. 0 serv/d HR: 0·78 0·25, 2·50 Age; race/ethnicity; education; marital status; BMI; vigorous physical activity; smoking; alcohol consumption; history of diabetes; family history of prostate cancer; screening for prostate cancer by use of prostate-specific antigen; and intakes of tomatoes, red meat, fish, vitamin E, alpha-linolenic acid, and total energy.
Kojima et al. 2014 JACC Japan 40–79 M: 45 181 9·9 79 Colon cancer mortality FFQ High v. low HR: 0·80 0·42, 1·51 Age, family history of colorectal cancer, BMI, frequency of alcohol intake, current smoking status, walking time per d and educational level
72 Rectal cancer mortality HR: 0·46 0·21, 1·02
40–79 F: 62 643 9·9 97 Colon cancer mortality High v. low HR: 0·97 0·61, 1·56
26 Rectal cancer mortality HR :1·51 0·60, 3·80
Matsumoto et al. 2007 JMS Japan 19–90 M/F: 11 606 9·15 255 Cancer mortality FFQ everyday v. not everyday HR: 1·48 0·59, 3·72 Sex and age
Goldbohm et al. 2011 NLCS The Netherlands 55–69 M: 12 912 10 10 658 All-cause mortality FFQ per 100 ml/d RR: 0·96 0·92, 1·00 Age, education, cigarette smoking; nonoccupational physical activity, BMI, multivitamin use, alcohol, energy, energy-adjusted mono- and polyunsaturated fat intakes, and vegetable and fruit consumption.
520 Stroke mortality RR: 0·68 0·51, 0·91
55–69 F: 7870 10 5478 All-cause mortality per 100 ml/d RR: 1·00 0·95, 1·05
322 Stroke mortality RR: 0·70 0·54, 0·92
Sakauchi et al. 2007 JACC Japan 40–79 F: 64 327 13·3 47 Ovarian cancer mortality FFQ > 1–2 times/week v. seldom HR: 1·66 0·71, 3·91 Age, menopausal status, number of pregnancies, history of sex hormone use, BMI, physical activity, and education
Khan et al. 2004 Hokkaido Japan > 40 M: 1524
F: 1634
14·8 155 Cancer mortality FFQ C2 v. C1 RR: 0·80 0·50, 1·30 Age and smoking
89 RR: 0·70 0·40, 1·30 Age, health status, health education, health screening and smoking
Tokui et al. 2005 JACC Japan 40–79 M: 45 181
F: 62 643
11 344 Stomach cancer mortality FFQ C5 v. C1 RR: 0·82 0·50, 1·37 Age
183 RR: 0·88 0·47, 1·64
Nakanishi et al. 2021 Yamagata Japan 40–74 F/M: 14 264 9 265 All-cause mortality FFQ C4 v. C1 HR: 0·62 0·42, 0·91 Age, gender, hypertension, diabetes mellitus, smoking, alcohol consumption, BMI and education period
7 40 CVD mortality HR: 1·06 0·39, 2·84
7 90 Cancer mortality HR: 0·53 0·27, 0·99
Lu et al. 2022 Miyagi Japan 40–64 M: 16 565 25 4304 All-cause mortality FFQ > 3 times/week v. almost never HR: 1·04 0·92, 1·17 Age, education level, BMI, smoking status, alcohol drinking status, history of hypertension, and history of diabetes, energy intake, fish intake, vegetable and fruit intake
1048 CVD mortality HR: 0·99 0·78, 1·26
1713 Cancer mortality HR: 1·03 0·85, 1·24
F: 17 596 2522 All-cause mortality HR: 0·92 0·81, 1·03
645 CVD mortality HR: 0·87 0·69, 1·11
839 Cancer mortality HR: 1·10 0·89, 1·34
Lin et al. 2022 NHANES USA > 18 F/M: 32 625 8·1 3881 All-cause mortality Food recall Consumer v. non-consumer HR: 0·83 0·71, 0·98 Age, sex, race, BMI, leucocytes count, Hb, platelet count, total bilirubin, creatinine, blood urea nitrogen, hypertension, diabetes, asthma, congestive heart failure, CHD, stroke, chronic bronchitis and cancer.
651 CVD mortality HR: 0·68 0·43, 1·08
863 Cancer mortality HR: 1·00 0·72, 1·38

RR, relative risk; F, female; g/d, gram(s) per d; HR, hazard ratio; serv, serving; NSCS, Nambour Skin Cancer Study; HPFS, Health Professionals Follow-Up Study; NHS, Nurses’ Health Study; GCS, Golestan Cohort Study; PURE, Prospective Urban Rural Epidemiology; EPIC-NL, European Prospective Investigation into Cancer and Nutrition – the Netherlands; RS, Rotterdam Study; NIH-AARP, National Institutes of Health-American Association of Retired Persons; JACC, Japan Collaborative Cohort Study; JMS, Jichi Medical School; NLCS, Netherlands Cohort Study; NHANES, National Health and Nutrition Examination Survey.